Best Practices for Intrathecal Baclofen Therapy: Dosing and Long-Term Management
Authors:
- 1 August 2016
- journal article
- review article
- Published by Elsevier in Neuromodulation: Technology at the Neural Interface
- Vol. 19 (6) , 623-631
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Long‐term Intrathecal Baclofen: Outcomes After More than 10 Years of TreatmentPM&R, 2013
- Polyanalgesic Consensus Conference 2012: Recommendations for the Management of Pain by Intrathecal (Intraspinal) Drug Delivery: Report of an Interdisciplinary Expert PanelNeuromodulation: Technology at the Neural Interface, 2012
- Efficacy of intrathecal baclofen therapy in children with intractable spastic cerebral palsy: A randomised controlled trialEuropean Journal of Paediatric Neurology, 2009
- Intrathecal Baclofen Management of Poststroke Spastic Hypertonia: Implications for Function and Quality of LifeArchives of Physical Medicine and Rehabilitation, 2006
- Long-term intrathecal baclofen therapy for severe spasticity of cerebral originJournal of Neurosurgery, 2003
- Long‐term safety and efficacy of continuous intrathecal baclofenDevelopmental Medicine & Child Neurology, 2002
- Intrathecal Baclofen for Management of Spastic Cerebral Palsy: Multicenter TrialJournal of Child Neurology, 2000
- Effect of intrathecal baclofen delivered by an implanted programmable pump on health related quality of life in patients with severe spasticityJournal of Neurology, Neurosurgery & Psychiatry, 1997
- Intrathecal baclofen for intractable spasticity of spinal origin: results of a long-term multicenter studyJournal of Neurosurgery, 1993
- Intrathecal baclofen for spasticity of spinal origin: seven years of experienceJournal of Neurosurgery, 1992